These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29926559)

  • 1. [From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event].
    Scheen AJ
    Rev Med Liege; 2018 May; 73(5-6):224-228. PubMed ID: 29926559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenesis and atherothrombosis--focus on diabetes mellitus.
    Stratmann B; Tschoepe D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):291-303. PubMed ID: 19520304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherothrombosis: a major health burden.
    Leys D
    Cerebrovasc Dis; 2001; 11 Suppl 2():1-4. PubMed ID: 11316915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherothrombosis and high-risk plaque: part I: evolving concepts.
    Fuster V; Moreno PR; Fayad ZA; Corti R; Badimon JJ
    J Am Coll Cardiol; 2005 Sep; 46(6):937-54. PubMed ID: 16168274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherothrombosis and the management of the vulnerable vascular patient.
    Arora R; Rai F
    Am J Ther; 2009; 16(1):24-34. PubMed ID: 19114877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherothrombosis as a systemic disease.
    Drouet L
    Cerebrovasc Dis; 2002; 13 Suppl 1():1-6. PubMed ID: 11803180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological aspects of atherosclerosis in patients treated for acute atherothrombosis of extremity arteries.
    Rustempasic N; Totic D; Djedovic M; Rustempasic M; Malesic N
    Med Arch; 2014 Oct; 68(5):329-31. PubMed ID: 25568565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis and thrombosis: lessons from animal models.
    Badimon L
    Thromb Haemost; 2001 Jul; 86(1):356-65. PubMed ID: 11487025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after ischaemic stroke/transient ischaemic attack.
    Hankey GJ
    Cerebrovasc Dis; 2003; 16 Suppl 1():14-9. PubMed ID: 12698014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive immunity in atherosclerosis.
    Packard RR; Lichtman AH; Libby P
    Semin Immunopathol; 2009 Jun; 31(1):5-22. PubMed ID: 19449008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].
    Suárez C; Castillo J; Esmatjes E; Sala J; Cairols M; Montoto C; Barberá G;
    Med Clin (Barc); 2009 Apr; 132(14):537-44. PubMed ID: 19393390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation.
    Ouweneel AB; Van Eck M
    Vascul Pharmacol; 2016 Jul; 82():1-10. PubMed ID: 26545626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy and vascular disease: an update.
    Buch MH; Prendergast BD; Storey RF
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional procedures for atherothrombosis: pathology of retrieved material.
    Angelini A; Della Barbera M; Thiene G
    Heart; 2007 Oct; 93(10):1301-8. PubMed ID: 17890710
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue Factor and Atherothrombosis.
    Tatsumi K; Mackman N
    J Atheroscler Thromb; 2015; 22(6):543-9. PubMed ID: 26016513
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.